Medical Oncology

Prof. Dr. Fahriye Tuğba Köş

Doctor and researcher Ankara Bilkent Şehir Hastanesi Ankara
Pancreatic NeoplasmsLung NeoplasmsColorectal NeoplasmsStomach NeoplasmsAdenocarcinomaCarcinoma, Non-Small-Cell LungBreast NeoplasmsBiliary Tract NeoplasmsLiver NeoplasmsCarcinoma, HepatocellularMelanomaNeuroendocrine TumorsSarcoma, EwingCarcinoma, Ductal, BreastCarcinoma, LobularNeoplasms, Multiple PrimaryNeoplasmsKidney Diseases
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Pancreatic Neoplasms 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 7 publications
  • Colorectal Neoplasms 7 publications
  • Stomach Neoplasms 6 publications
  • Adenocarcinoma 6 publications
  • Carcinoma, Non-Small-Cell Lung 5 publications
  • Breast Neoplasms 5 publications
  • Biliary Tract Neoplasms 3 publications
  • Liver Neoplasms 3 publications
  • Carcinoma, Hepatocellular 2 publications
  • Melanoma 2 publications
  • Neuroendocrine Tumors 2 publications
  • Sarcoma, Ewing 2 publications
  • Carcinoma, Ductal, Breast 2 publications
  • Carcinoma, Lobular 2 publications
  • Neoplasms, Multiple Primary 2 publications
  • Neoplasms 2 publications
  • Kidney Diseases 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
  • Area of workPancreatic NeoplasmsExtracted from 9 publications · Model version —From source
  • Publications109 publicationsOpenAlex, Europe PMCFrom source
  • ORCID0000-0002-6980-4942ORCIDFrom source
  • Last synchronised5 November 2026 07:23https://ankarasehir.saglik.gov.tr/TR-331078/tibbi-onkoloji-klinigi-doktorlarimiz.html#fahriye-tugba-kossaglik.gov.tr

Scientific work

Publications on Pancreatic Neoplasms

109 publications

  1. Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04842-3 PMID 41870760 Open-access full textSource: OpenAlex

  2. Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma

    Future oncology (London, England), 2026

    DOI 10.1080/14796694.2026.2732589 PMID 42730632 Source: Europe PMC

  3. Pembrolizumab associated immune thrombocytopenia

    Journal of chemotherapy (Florence, Italy), 2026

    DOI 10.1080/1120009x.2025.2468045 PMID 39972542 Source: Europe PMC

  4. Re: Three versus Six Cycles of Platinum-Based Chemotherapy Followed by Avelumab Maintenance as First-Line Treatment for Advanced Urothelial Cancer: The Phase II DISCUS Trial

    European Urology, 2026

    DOI 10.1016/j.eururo.2026.03.010 PMID 41925429 Source: OpenAlex

  5. Nailfold capillaroscopy findings after anthracycline-based chemotherapy and their association with subclinical changes in left ventricular ejection fraction

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16187-9 PMID 42151866 Open-access full textSource: OpenAlex

  6. Survival Outcomes in ERBB2- Low vs ERBB2- Null Advanced Gastric Cancer

    JAMA Network Open, 2026

    DOI 10.1001/jamanetworkopen.2026.24180 PMID 42479431 Open-access full textSource: OpenAlex

  7. Timing of Second-Line Nivolumab and Survival in Metastatic Renal Cell Carcinoma

    Clinical Genitourinary Cancer, 2026

    DOI 10.1016/j.clgc.2026.102653 PMID 42700745 Source: OpenAlex

  8. Clinical and microbiological characteristics of abscesses in patients with malignancy and factors associated with 90-day mortality

    Frontiers in Cellular and Infection Microbiology, 2026

    DOI 10.3389/fcimb.2026.1969735 Open-access full textSource: OpenAlex

  9. Preoperative 18F-fluorodeoxyglucose PET/computed tomography maximum standardized uptake value is independently associated with overall survival in surgically resected undifferentiated pleomorphic sarcoma

    Nuclear Medicine Communications, 2026

    DOI 10.1097/mnm.0000000000002255 PMID 42929044 Source: OpenAlex

  10. Survival–Toxicity Trade-Offs Between Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer: A Simulation-Based Reinforcement Learning Study

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.2612601 Source: OpenAlex

View all 109 publications